Home » Topics » Conferences

Conferences
RSS

Aphton and SmithKline Beecham form alliance for Gonadimmune

June 22, 1998

SB-T-101131, a second-generation taxane with improved efficacy in MDR tumors

June 22, 1998

L-NDDP, a liposomal cisplatin derivative in phase II testing

June 22, 1998

Combretastatin potentiates antitumor efficacy of chemo- and radiotherapy in preclinical studies

June 22, 1998

BBR-3438, a promising new agent for prostate cancer

June 22, 1998

Lilly's oral diarylsulfonylurea LY-295501 profiled at NCI-EORTC meeting

June 22, 1998

Symphar, SmithKline Beecham collaborate in the discovery of Lp(a)-lowering agents

June 22, 1998

Bay-12-9566: a promising anticancer compound progresses to phase III at Bayer

June 22, 1998

Russian scientists evaluate the antitumor activity of betaleukin

June 22, 1998

Telomerase inhibitors in early development at CRC

June 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...